Donor heart preservation with three different solutions: donor heart function at more than 1 year after transplantation.
Weyand
M
M
Department of Cardiothoracic Surgery, University of Kiel, Federal Republic of Germany.
Konertz
W
W
Deiwick
M
M
Hachenberg
T
T
Scheld
H H
HH
Bernhard
A
A
D000328:Adult; D001639:Bicarbonates / Q000008:administration & dosage; D002122:Calcium Chloride / Q000008:administration & dosage; D002302:Cardiac Output / Q000502:physiology; D005500:Follow-Up Studies; D005947:Glucose / Q000008:administration & dosage; D006084:Graft Rejection / Q000503:physiopathology*; D016027:Heart Transplantation / Q000502:physiology*; D006801:Humans; D006982:Hypertonic Solutions / Q000008:administration & dosage*; D008274:Magnesium / Q000008:administration & dosage; D008353:Mannitol / Q000008:administration & dosage; D009926:Organ Preservation / Q000379:methods*; D011183:Postoperative Complications / Q000503:physiopathology*; D011189:Potassium Chloride / Q000008:administration & dosage; D011343:Procaine / Q000008:administration & dosage; D012965:Sodium Chloride / Q000008:administration & dosage
D001639:Bicarbonates; C039984:Bretschneider cardioplegic solution; C037096:Euro-Collins' solution; D006982:Hypertonic Solutions; C041711:St. Thomas' Hospital cardioplegic solution; D008353:Mannitol; D012965:Sodium Chloride; D011343:Procaine; D011189:Potassium Chloride; D008274:Magnesium; D005947:Glucose; D002122:Calcium Chloride